Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +734.12%
#3 ADO Protocol ADO Protocol +101.66%
#4 Cortex Cortex +93.48%
#5 Ontology Gas Ontology Gas +74.08%
#6 Kinesis Silver Kinesis Silver +53.91%
#7 Magma Finance Magma Finance +27.64%
#8 OpenEden OpenEden +26.06%
#9 PondCoin PondCoin +25.14%
#10 QuantixAI QuantixAI +23.16%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Axcella Health Inc. Axcella Health Inc.

Axcella Health Inc.

AXLA
Rank in Stocks #18694
Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused... Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical trials, where it is being evaluated for its potential to lower the risk of recurrent overt hepatic encephalopathy. Meanwhile, AXA1125 is progressing through multiple trials: a Phase 2b study targeting non-alcoholic steatohepatitis (NASH) treatment, and a Phase 2a study exploring its efficacy as a therapy for Long COVID patients. Founded in 2008, the entity initially operated as Newco LS16, Inc. before officially adopting the name Axcella Health Inc. in June 2016. Its operations are headquartered in Cambridge, Massachusetts.
Share Price
$4.58
Last synced: 2025-02-06
Market Cap
$189.73M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Axcella Health Inc. (AXLA)

Category

Healthcare
Revenue for Axcella Health Inc. (AXLA)
Revenue in Aug 2026 TTM: 0
According to Axcella Health Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Axcella Health Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH